Digital Health Digest | Meri Beckwith

Welcome to the Digital Health Digest series, hosted by Ellis Ward, Head of Digital Health Commercial. Join us in this Q&A series as we explore enlightening discussions with a wide range of individuals, including startup founders, investors, thought leaders, and influencers in the Digital Health field.

Interview with Meri Beckwith, co-founder of Lindus Health

In this interview, Ellis and Meri discuss the most common misconceptions when considering clinical trials for digital health solutions, why digital health companies should conduct clinical trials and the post-clinical trial process. They also delve into the increase in poly-indication digital health solutions and how this is currently impacting the digital health industry. 

The interview is rounded off with Meri’s predictions for what’s in store for the digital health industry in 2024 and beyond. 

About Meri Beckwith:

Meri is the co-founder of Lindus Health. Lindus Health runs radically faster, more reliable clinical trials for life science pioneers – including digital health organisations. Prior to this Meri spent some years as a health and biotech VC investor, and a serial clinical trial participant. This is where he experienced first-hand how clinical trial outcomes could be improved for both sponsors and patients, and Lindus Health was born.